D-0012-2027 Class II Ongoing

Recalled by BioSpectra, Inc. — Bangor, PA

FDA drug recall D-0012-2027 was initiated by BioSpectra, Inc. on Jul 29, 2026 and is designated Class II. Reason for recall: Failed stability specifications The recall status is ongoing. Affected quantity: 200 kg.

Recall details

Product Type
Drugs
Report Date
Oct 14, 2026
Initiation Date
Jul 29, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
200 kg

Product description

Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

Reason for recall

Failed stability specifications

Distribution pattern

CA

Code information

Lot#: TRIS -E04-0226-0016; Exp 2/29/28

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0012-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0012-2027. Report a data issue: hello@regdatalab.com.